Cost Per Mg Peptide Comparison Chart: How It's Calculated
A cost per mg peptide comparison chart converts vial price into one comparable unit across compounds, vial sizes, and listing revision dates for research use.
Reviewed by Benjamin Clark, MD, internal medicine physician ·
Benjamin Clark, MD is a board-certified internal medicine physician with clinical and academic training in evidence-based pharmacotherapy at Vanderbilt University Medical Center.
- cost
- pricing
- peptides
- comparison
A cost per mg peptide comparison chart exists to solve one problem: vial price by itself tells a reader almost nothing, because vial sizes vary from compound to compound and from supplier to supplier. A $70 vial containing 2 mg of peptide is a different value proposition than a $70 vial containing 10 mg, and a chart that lists only the sticker price hides that difference entirely. Dividing price by milligram content turns every listing into the same unit, which is what makes a cost per mg peptide comparison chart useful for comparing across a whole catalogue rather than one product at a time.
Why Vial Price Alone Is Misleading
Two listings for the same compound can carry identical sticker prices while representing very different value, simply because one vial holds more peptide mass than the other. A chart that sorts by raw price will rank the smaller vial as equal to the larger one, even though the cost per milligram of actual peptide differs. This is why a comparison chart built around cost per mg, rather than cost per vial, is the more reliable way to line up listings that differ in size, concentration, or packaging convention.
The same distortion shows up when comparing across compounds. A peptide that ships almost exclusively in small vials will look expensive on a price-only chart next to a peptide that ships in large multi-milligram vials, even if their actual cost per milligram is close. Normalizing to a per-mg figure removes vial size as a confounding variable and leaves only the underlying price-per-unit-mass comparison.
How the Cost-Per-Mg Figure Is Calculated
The calculation itself is simple division: take the listed vial price and divide it by the milligram content stated on the label or certificate of analysis. The result is expressed as dollars (or whichever currency) per milligram, which is the unit a cost per mg peptide comparison chart sorts and displays.
As a worked, illustrative example: a hypothetical vial listed at $60 and labeled as containing 5 mg of peptide gives a cost per mg of $60 ÷ 5 mg = $12/mg. A second hypothetical vial from a different listing, priced at $90 for 10 mg, works out to $90 ÷ 10 mg = $9/mg. Despite the second vial carrying a higher sticker price, its cost per mg is lower, which is exactly the kind of ranking a price-only chart would get backwards. Checking the arithmetic a second way confirms both figures: $12/mg × 5 mg = $60, and $9/mg × 10 mg = $90, both matching the original listed prices.
This same division applies regardless of which compound is in the vial. The formula does not change for a single-target compound versus a multi-target one, or for a short peptide versus a longer one — only the price and mg figures that go into it change, which is what makes a single chart format usable across an entire catalogue.
What a Comparison Chart Should Display
A cost per mg peptide comparison chart is only as useful as the fields it exposes alongside the calculated figure. The table below outlines what each field contributes to a reader trying to compare listings honestly.
| Chart field | What it tells the reader |
|---|---|
| Vial price | Raw listed cost, before normalization |
| Stated mg content | The mass figure the per-mg calculation depends on |
| Calculated cost/mg | Price divided by mg — the comparable unit |
| Vial size (mL, if pre-mixed) | Relevant only for pre-mixed liquid listings, not lyophilized powder |
| Revision date | When the listed price was last confirmed accurate |
Omitting the stated mg content and showing only the calculated cost/mg figure removes the reader’s ability to verify the math, so a chart that hides its inputs is harder to trust than one that shows both the raw price and the mg figure it was divided by.
Why Revision Dates Matter on a Cost Chart
Peptide listing prices change more often than most reference content does, so a cost per mg peptide comparison chart that does not carry a visible revision date is effectively presenting a snapshot as if it were current. A reader has no way to know whether a given row reflects this week’s pricing or a figure that has not been checked in months.
A revision date does not guarantee the underlying price is still accurate at the moment a reader views the chart — supplier pricing can move between revisions — but it does let a reader judge how stale a given row might be. A chart with per-row revision dates is more useful than one with a single “last updated” note at the top of the page, since different compounds on the same chart are rarely repriced on the same schedule.
Cross-Checking Mg Content Against the Source Listing
The cost-per-mg figure is only as reliable as the mg content it was divided by, so it is worth checking that figure against the vial’s own certificate of analysis rather than trusting a chart’s stated number alone. For a compound like semaglutide, cross-referencing the mg content and concentration figures published on the manufacturer’s own product page is a reasonable sanity check before treating a calculated cost-per-mg figure as settled.
This matters most when a listing’s stated mg content and its reconstituted concentration do not obviously match. If a vial’s label states 5 mg and a separate reconstitution note on the same page implies a different total mass, that inconsistency should be resolved before the cost-per-mg figure derived from either number is trusted. A well-documented listing states vial mg content plainly and does not require a reader to reverse-engineer it from concentration and volume figures, a documentation standard covered in more detail across peer research-peptide catalogs.
Common Pitfalls When Reading a Cost-Per-Mg Chart
A few recurring issues make cost-per-mg comparisons less reliable than they look at first glance. Bundle pricing — where a listing quotes a lower per-vial price for a multi-vial pack — needs to be normalized to a single-vial basis before it is compared against single-vial listings, or the bundle will appear artificially cheaper per mg. Shipping and handling fees are sometimes included in a listed price and sometimes added at checkout, which changes the effective cost-per-mg figure without changing the number printed on the product page.
Currency and unit conventions can also differ between listings, particularly on sites that mix per-vial and per-mL pricing for pre-mixed liquid products. A chart comparing lyophilized powder against a pre-mixed liquid needs to convert the liquid listing’s per-mL price to a per-mg figure using its stated concentration before the two rows are comparable at all.
Summary
A cost per mg peptide comparison chart is a normalization tool: it takes listed vial prices, which vary by vial size and packaging convention, and converts them into a single comparable unit by dividing price by stated milligram content. The calculation itself is straightforward division, but the chart is only as trustworthy as the inputs it exposes — stated mg content, a visible revision date, and pricing that has been normalized for bundles, shipping, and unit conventions before comparison.